Blue Rock Advisors, LLC - AXOVANT GENE THERAPIES LTD ownership

AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 1 filers reported holding AXOVANT GENE THERAPIES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Blue Rock Advisors, LLC ownership history of AXOVANT GENE THERAPIES LTD
ValueSharesWeighting
Q3 2020$373,00080,7320.32%
Other shareholders

There were no reported owners of AXOVANT GENE THERAPIES LTD in Q4 2020.

NameSharesValueWeighting ↓
View complete list of AXOVANT GENE THERAPIES LTD shareholders